Emergent BioSolutions Inc. (NYSE:EBS) Q2 2022 Results Conference Call August 1, 2022 5:00 PM ET Company Participants Bob Burrows - Vice President of Investor Relations Bob Kramer - President and Chief Executive Officer Rich Lindahl - Chief Financial Officer Conference Call Participants Brandon Folkes - Cantor Jessica Fye - JPMorgan Joichi Sakai - Singular Research Operator Thank you for standing by, and welcome to the Emergent BioSolutions Second Quarter 2022 Earnings Conference Call. At this time, all part ...

Emergent BioSolutions Inc. (NYSE:EBS) Q1 2022 Results Conference Call April 28, 2022 5:00 PM ET Company Participants Bob Burrows - VP, IR Bob Kramer - President and CEO Rich Lindahl - CFO Conference Call Participants Brandon Folkes - Cantor Fitzgerald Lisa Springer - Singular Research Operator Good day, and thank you for standing by. Welcome to the First Quarter 2022 Emergent BioSolutions Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, ther ...

Emergent BioSolutions Inc. (NYSE:EBS) Q4 2021 Earnings Conference Call February 24, 2022 5:00 PM ET Company Participants Bob Burrows - IR Officer Bob Kramer - President and CEO Rich Lindahl - CFO Adam Havey - Chief Operating Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald Jessica Fye - JPMorgan Jacob Hughes - Wells Fargo Keay Nakae - Chardan Lisa Springer - Singular Research Operator Good day, and thank you for standing by. Welcome to the Q4 2021 Emergent BioSolutions Incorporated Ea ...

Emergent Biosolutions, Inc. (NYSE:EBS) Q2 2021 Earnings Conference Call July 29, 2021 5:00 PM ET Company Participants Bob Burrows – Investor Relations Bob Kramer – President and Chief Executive Officer Rich Lindahl – Chief Financial Officer Conference Call Participants Brandon Folkes – Cantor Fitzgerald Jessica Fye – JPMorgan Jacob Hughes – Wells Fargo Securities Keay Nakae – Chardan Lisa Springer – Singular Research Operator Ladies and gentlemen, thank you for standing by, and welcome to the Emergent BioSo ...

Emergent BioSolutions, Inc. (NYSE:EBS) Q1 2021 Earnings Conference Call April 29, 2021 5:00 PM ET Company Participants Robert Burrows - VP, IR Robert Kramer - CEO, President & Executive Director Richard Lindahl - EVP, CFO & Treasurer Adam Havey - EVP, Business Operations Conference Call Participants Brandon Folkes - Cantor Fitzgerald & Co. Dana Flanders - Guggenheim Securities Jessica Fye - JPMorgan Chase & Co. Keay Nakae - Chardan Capital Markets Lisa Springer - Singular Research Operator Thank you for sta ...